Animal Study Results
-
Test Substance
Chrysanthemum & Ecklonia Cava Extract Complex
-
Study Design
PMA-induced lung epithelial cell (A549) model
ED : Chrysanthemum & Ecklonia Cava Extract Complex
Inhibitory Effect on Mucus
Hypersecretion Inhibition of MAPK Signaling Pathway
*Treatment with the Chrysanthemum & Ecklonia Cava Extract Complex (ED) showed dose-dependent inhibition of MUC5AC expression,
with a particularly potent inhibitory effect observed at 40µg/mL.
*The Chrysanthemum & Ecklonia Cava Extract Complex (ED) significantly inhibited the PMA-activated phosphorylation of p-ERK, p-JNK, and p-p38.
*It was demonstrated that the Chrysanthemum & Ecklonia Cava Extract Complex inhibits the expression of MUC5AC,
the major gene for mucus production, by blocking the activation of the MAPK pathway induced by PMA.
-
Test Substance
Chrysanthemum & Ecklonia Cava Extract Complex
-
Study Design
Treatment Group: Oral administration of ED (Chrysanthemum & Ecklonia Cava Extract Complex, 300mg/kg)
Positive Control Group: Oral administration of Bronpass* (300mg/kg)
Negative Control Group: Oral administration of DW (Distilled Water)
*Bronpass = A pharmaceutical drug for acute bronchitis
Improvement Effect on Bronchial Inflammation
*Analysis of the bronchoalveolar lavage fluid (BALF) showed a large infiltration of inflammatory cells in the group treated with OVA (ovalbumin) alone.
However, the number of inflammatory cells was reduced in the group administered with the Chrysanthemum & Ecklonia Cava Extract Complex (ED).
*Quantitative analysis revealed that the administration of the Chrysanthemum & Ecklonia Cava Extract Complex (ED)
after OVA induction decreased the number of inflammatory cells, demonstrating an effect similar to that of the positive control group.
Anti-inflammatory and Anti-mucus Effects
*In the H&E staining results, the OVA-treated group exhibited thickened alveolar walls and a large infiltration of inflammatory cells.
In contrast, the group administered with the Chrysanthemum & Ecklonia Cava Extract Complex (ED) showed preserved tissue structure and a reduced pattern of inflammatory cell infiltration.
*The PAS staining results confirmed that the OVA-treated group was stained dark purple due to mucus accumulation.
In contrast, the group administered with the Chrysanthemum & Ecklonia Cava Extract Complex (ED) showed a distinct pattern of suppressed mucus secretion.
Inhibitory Effect on Inflammatory Cytokines
Serum Analysis
- Analysis of inflammation-related gene expression in lung tissue confirmed that the expression of COX-2, iNOS, TNF-α, and IL-1β was significantly increased in the OVA-treated group. Administration of the Chrysanthemum & Ecklonia Cava Extract Complex (ED) was confirmed to significantly suppress this inflammatory gene expression.
- Measurement of serum IL-6 levels by ELISA confirmed that the IL-6 level was significantly lower in the group administered with the Chrysanthemum & Ecklonia Cava Extract Complex (ED).
- Overall, the effects were similar to those of the positive control group, and for some factors, the effects were even superior.
Amelioration of Pulmonary Inflammation
-
Test Substance
Chrysanthemum & Ecklonia Cava Extract Complex
-
Study Design
*Particulate Matter (PM2.5)-induced lung inflammation BALB/c mouse model
Treatment Group: Oral administration of ED (Chrysanthemum & Ecklonia Cava Extract Complex, 300mg/kg)
*Positive Control Group: Oral administration of Bronpass* (300mg/kg)
*Negative Control Group: Oral administration of DW (Distilled Water)
*Bronpass = A pharmaceutical drug for acute bronchitis
Improvement in Inflammatory Cell Count in Bronchoalveolar Lavage Fluid (BALF)
Improvement Effect on Tissue Inflammation via H&E and PAS Staining
*Analysis of the total inflammatory cell count in the BALF showed that the number of inflammatory cells was markedly increased in the PM2.5-treated group.
In the group administered with the Chrysanthemum & Ecklonia Cava Extract Complex (ED),
the inflammatory cell count was not only significantly decreased but also showed an effect superior to that of the positive control group.
*Histological analysis revealed that the PM2.5-treated group exhibited lung tissue damage, inflammatory cell infiltration, and mucus hypersecretion.
In contrast, the group administered with the Chrysanthemum & Ecklonia Cava Extract Complex (ED) showed preserved tissue structure,
and inflammatory responses and mucus production were markedly suppressed.
Inhibitory Effect on Serum Inflammatory Cytokines
Inhibitory Effect on Inflammatory Gene Expression in Lung Tissue
*Analysis of serum inflammatory cytokine levels showed that TNF-α and IL-6 levels were increased by PM2.5.
Upon administration of the Chrysanthemum & Ecklonia Cava Extract Complex (ED), both indicators were significantly decreased.
*Analysis of inflammatory gene expression in lung tissue showed that the expression of TNF-α, IL-1β, and IL-6 was greatly increased in the PM2.5-treated group.
However, in the group administered with the Chrysanthemum & Ecklonia Cava Extract Complex (ED), all these indicators were confirmed to be significantly suppressed.